LigaChem Biosciences, Inc.
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 2006-05-01
- Employees
- 147
- Market Cap
- -
- Website
- http://www.legochembio.com
Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex
- Conditions
- Interventions
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06004037
- Locations
- π°π·
Bundang Seoul National University Hospital, Seoul, Korea, Republic of
π°π·Asan Medical Center, Seoul, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT05941507
- Locations
- πΊπΈ
Cedars Sinai Medical Center, Los Angeles, California, United States
πΊπΈDana Farber Cancer Institute, Boston, Massachusetts, United States
π¨π¦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia
- Conditions
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05225558
- Locations
- π°π·
Korea University Ansan Hospital, Ansan, Korea, Republic of
π°π·Seoul National University Bundang Hospital, Seoul, Korea, Republic of
π°π·Severance Hospital, Seoul, Korea, Republic of
Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches
- Conditions
- Interventions
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04939779
- Locations
- π°π·
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
- Conditions
- Interventions
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT04550832
- Locations
- πΉπΏ
Ifakara Health Institute, Bagamoyo, Tanzania
πΏπ¦The Aurum Institute Tembisa Clinical Research Centre, Tembisa, Gauteng, South Africa
πΏπ¦Clinical HIV Research Unit (CHRU) University of the Witwatersrand, Johannesburg, South Africa
A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace
- Conditions
- Interventions
- First Posted Date
- 2018-04-10
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT03492996
- Locations
- π°π·
Seoul National University Hospital, Seoul, Korea, Republic of
IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02882789
- Locations
- π°π·
Bae KS, Seoul, Korea, Republic of
A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2020-02-06
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 79
- Registration Number
- NCT02836483
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371
- Conditions
- Interventions
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02540460
- Locations
- π°π·
Seoul National University Bundang Hospital, Bundang, Gyeonggi, Korea, Republic of
To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371
- Conditions
- Interventions
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2016-03-23
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02538003
- Locations
- π°π·
Seoul National University Bundang Hospital, Bundang, Gyeonggi, Korea, Republic of